THR
Thermon Group Holdings, Inc. · Industrials · Specialty Industrial Machinery
Last
$61.14
−$5.67 (−8.49%) 4:00 PM ET
After hours $61.14 +$0.00 (+0.00%) 3:33 AM ET
Prev close $66.81
Open $67.40
Day high $67.41
Day low $60.05
Volume 1,107,999
Avg vol 741,428
Mkt cap
$2.01B
P/E ratio
45.29
FY Revenue
$536.26M
EPS
1.35
Gross Margin
45.32%
Sector
Industrials
AI report sections
THR
Thermon Group Holdings, Inc.
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
+116% (Above avg)
Vol/Avg: 2.16×
RSI
46.33 (Neutral)
Neutral (40–60)
MACD momentum
Intraday
+0.03 (Strong)
MACD: -0.03 Signal: -0.06
Short-Term
-0.65 (Weak)
MACD: 2.23 Signal: 2.88
Long-Term
-0.32 (Weak)
MACD: 4.88 Signal: 5.20
Intraday trend score 36.00

Latest news

THR 12 articles Positive: 2 Neutral: 2 Negative: 2
Neutral GlobeNewswire Inc. • Na
CECO Environmental and Thermon Group Holdings Announce Election Deadline for Thermon Stockholders to Elect Form of Merger Consideration

CECO Environmental has set May 22, 2026 as the election deadline for Thermon stockholders to choose their merger consideration form in the pending acquisition. Thermon shareholders can elect to receive 0.8110 CECO shares, a mix of 0.6840 CECO shares plus $10 cash, or $63.89 in cash. The transaction is expected to close on June 1, 2026, subject to stockholder approval and customary closing conditions.

CECO THR merger acquisition stockholder election merger consideration stock consideration cash consideration
Sentiment note

Thermon is being acquired by CECO. While the acquisition itself is a significant corporate event, the announcement is procedural in nature, setting election deadlines for stockholders. The sentiment is neutral as this represents a transaction already agreed upon with clear terms being executed.

Negative GlobeNewswire Inc. • Brodsky & Smith
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: KalVista Pharmaceuticals, Inc. (Nasdaq – KALV), Thermon Group Holdings, Inc. (NYSE – THR), Sila Realty Trust, Inc. (NYSE – SILA), Lisata Therapeutics, Inc. (Nasdaq – LSTA)

Law firm Brodsky & Smith has initiated investigations into four merger transactions, examining whether the boards of KalVista Pharmaceuticals, Thermon Group Holdings, Sila Realty Trust, and Lisata Therapeutics breached fiduciary duties by failing to conduct fair processes and potentially underpaying shareholders. The deals range in value from approximately $1.9 billion to $2.4 billion.

KALV THR SILA LSTA merger investigation fiduciary duty shareholder litigation fair value
Sentiment note

Under investigation for potential breach of fiduciary duties regarding fair process and fair value in stock and cash transaction valued at $2.2 billion

Positive GlobeNewswire Inc. • Na
CECO Environmental and Thermon to Host Joint CEO Fireside Chat at Upcoming Roth Conference

CECO Environmental Corp. and Thermon Group Holdings, Inc. announced a joint fireside chat featuring both CEOs at the 38th Annual Roth Conference on March 23, 2026. The webcast will be available on both companies' investor relations websites. CECO also recently raised its full year 2026 orders outlook to exceed $1.5 billion, with the Thermon transaction remaining on track to close in mid-2026.

CECO THR fireside chat Roth Conference investor relations orders outlook acquisition industrial solutions
Sentiment note

Thermon is being acquired by CECO with the transaction on track to close in mid-2026, representing a significant strategic transaction. The joint investor conference appearance demonstrates continued engagement with stakeholders during the acquisition process.

Neutral The Motley Fool • John Ballard
Meros Investment Management Sold 396,804 Shares of Photronics Stock

Meros Investment Management reduced its stake in Photronics by 396,804 shares in Q4 2025, selling approximately $10 million worth. The fund retained 108,004 shares valued at $3.4 million, representing 1.4% of AUM. The sale reflects a value investing strategy to lock in gains after Photronics' strong 74.2% annual performance, while the fund reallocated capital to other undervalued holdings.

PLAB DCO MGNI THR Photronics Meros Investment Management stock sale Q4 2025
Sentiment note

Meros reduced its stake in Thermon alongside Photronics after strong outperformance, suggesting a similar profit-taking strategy rather than negative outlook.

Negative Benzinga • Prnewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Thermon Group Holdings, Inc. (NYSE: THR)

Monteverde & Associates PC, a securities class action firm, has announced an investigation into Thermon Group Holdings, Inc. (NYSE: THR) regarding its proposed sale to CECO Environmental Corp. The investigation seeks to determine whether the merger terms are fair to Thermon shareholders, who may elect to receive various combinations of cash and CECO stock.

THR CECO class action merger investigation shareholder fairness M&A deal securities litigation
Sentiment note

The announcement of a class action investigation into the fairness of the company's merger deal raises concerns about potential shareholder value and deal terms, suggesting possible legal challenges ahead.

Positive Benzinga • Lekha Gupta
Thermon Group Stock Soars Following Combination With CECO Environmental

Thermon Group Holdings (NYSE:THR) shares surged 18.55% in premarket trading following announcement of a $2.2 billion strategic combination with CECO Environmental Corp (NASDAQ:CECO). The deal offers Thermon shareholders multiple consideration options, implying a value of approximately $63.13 per share, representing a 26.8% premium to the previous closing price. The combined company is expected to achieve $40 million in annual cost synergies within 36 months and will be positioned to capitalize on energy transition and decarbonization trends. The transaction is expected to close mid-2026.

THR CECO merger acquisition strategic combination industrial solutions energy transition cost synergies
Sentiment note

Stock surged 18.55% in premarket trading to a new 52-week high following announcement of a strategic combination valued at $2.2 billion. The deal offers a 26.8% premium to the previous closing price and positions the combined company to benefit from long-term growth tailwinds in energy transition and decarbonization.

Unknown Zacks Investment Research • Zacks Equity Research
After Plunging -18.3% in 4 Weeks, Here's Why the Trend Might Reverse for Thermon Group (THR)

Thermon Group (THR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

THR
Unknown Zacks Investment Research • Zacks Equity Research
Thermon Group (THR) is on the Move, Here's Why the Trend Could be Sustainable

Thermon Group (THR) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

THR
Unknown Zacks Investment Research • Zacks Equity Research
LiveOne (LVO) Q4 Loss Wider Than Expected, Revenues Up Y/Y

LiveOne (LVO) posts healthy revenue growth of 21% year over year for the fiscal fourth quarter, driven by solid momentum in the Audio Division along with the execution of cost-effective strategies.

BMI WWD THR LVO
Unknown Zacks Investment Research • Zacks Equity Research
Thermon Group's (THR) Q4 Earnings Beat, Revenues Rise Y/Y

Thermon Group (THR) posts healthy fiscal fourth quarter performance driven by decarbonization initiatives and strong sales across diversified end markets.

BLKB CDNS THR BB
Unknown Zacks Investment Research • Zacks Equity Research
Thermon Group (THR) Beats Q4 Earnings and Revenue Estimates

Thermon Group (THR) delivered earnings and revenue surprises of 6.25% and 0.37%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

THR NTAP
Unknown Zacks Investment Research • Zacks Equity Research
Transcat, Inc. (TRNS) Q4 Earnings and Revenues Surpass Estimates

Transcat (TRNS) delivered earnings and revenue surprises of 48.08% and 3.14%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

TRNS THR
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal